These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 36185276)
1. Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma. Liu YF; Chiang Y; Hsu FM; Tsai CL; Cheng JC Front Oncol; 2022; 12():1009089. PubMed ID: 36185276 [TBL] [Abstract][Full Text] [Related]
2. Synergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation. Son CH; Keum JH; Yang K; Nam J; Kim MJ; Kim SH; Kang CD; Oh SO; Kim CD; Park YS; Bae J Radiat Oncol; 2014 Feb; 9():49. PubMed ID: 24512718 [TBL] [Abstract][Full Text] [Related]
3. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells. Zhu S; Denman CJ; Cobanoglu ZS; Kiany S; Lau CC; Gottschalk SM; Hughes DP; Kleinerman ES; Lee DA Pharm Res; 2015 Mar; 32(3):779-92. PubMed ID: 24203492 [TBL] [Abstract][Full Text] [Related]
4. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634 [TBL] [Abstract][Full Text] [Related]
5. The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC. Ponath V; Frech M; Bittermann M; Al Khayer R; Neubauer A; Brendel C; Pogge von Strandmann E Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33023028 [TBL] [Abstract][Full Text] [Related]
6. microRNA-889 is downregulated by histone deacetylase inhibitors and confers resistance to natural killer cytotoxicity in hepatocellular carcinoma cells. Xie H; Zhang Q; Zhou H; Zhou J; Zhang J; Jiang Y; Wang J; Meng X; Zeng L; Jiang X Cytotechnology; 2018 Apr; 70(2):513-521. PubMed ID: 28550492 [TBL] [Abstract][Full Text] [Related]
7. CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy. Han Y; Sun F; Zhang X; Wang T; Jiang J; Cai J; Gao Q; Hezam K; Liu Y; Xie J; Wang M; Zhang J J Cancer Res Clin Oncol; 2019 May; 145(5):1179-1190. PubMed ID: 30778749 [TBL] [Abstract][Full Text] [Related]
8. An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma. Mantovani S; Varchetta S; Mele D; Donadon M; Torzilli G; Soldani C; Franceschini B; Porta C; Chiellino S; Pedrazzoli P; Santambrogio R; Barabino M; Cigala C; Piccolo G; Opocher E; Maestri M; Sangiovanni A; Bernuzzi S; Lhospice F; Kraiem M; Mondelli MU; Oliviero B Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33266137 [TBL] [Abstract][Full Text] [Related]
10. Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro. Freese K; Seitz T; Dietrich P; Lee SML; Thasler WE; Bosserhoff A; Hellerbrand C Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635225 [TBL] [Abstract][Full Text] [Related]
11. Pan-HDAC inhibitors augment IL2-induced proliferation of NK cells via the JAK2-STAT5B signaling pathway. Zheng J; Lu Y; Xiao J; Duan Y; Zong S; Chen X; Hu T; Li L; Zhang Y Int Immunopharmacol; 2023 Mar; 116():109753. PubMed ID: 36738675 [TBL] [Abstract][Full Text] [Related]
12. Differential Effects of Histone Deacetylases on the Expression of NKG2D Ligands and NK Cell-Mediated Anticancer Immunity in Lung Cancer Cells. Cho H; Son WC; Lee YS; Youn EJ; Kang CD; Park YS; Bae J Molecules; 2021 Jun; 26(13):. PubMed ID: 34203519 [TBL] [Abstract][Full Text] [Related]
13. Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma. Wu X; Tao Y; Hou J; Meng X; Shi J Neoplasia; 2012 Dec; 14(12):1178-89. PubMed ID: 23308050 [TBL] [Abstract][Full Text] [Related]
15. Liu M; Du M; Yu J; Qian Z; Gao Y; Pan W; Zhao X; Wang M; Li H; Zheng J; Huang Q; Wang LM; Xiao H Oncoimmunology; 2022; 11(1):2016158. PubMed ID: 35003895 [TBL] [Abstract][Full Text] [Related]
16. The histone deacetylase inhibitor SAHA simultaneously reactivates HIV-1 from latency and up-regulates NKG2D ligands sensitizing for natural killer cell cytotoxicity. Desimio MG; Giuliani E; Doria M Virology; 2017 Oct; 510():9-21. PubMed ID: 28689087 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility. Shiraishi K; Mimura K; Kua LF; Koh V; Siang LK; Nakajima S; Fujii H; Shabbir A; Yong WP; So J; Takenoshita S; Kono K J Gastroenterol; 2016 Dec; 51(12):1101-1111. PubMed ID: 27002316 [TBL] [Abstract][Full Text] [Related]
18. Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency. Covino DA; Desimio MG; Doria M Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206330 [TBL] [Abstract][Full Text] [Related]
19. Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation. He S; Yin T; Li D; Gao X; Wan Y; Ma X; Ye T; Guo F; Sun J; Lin Z; Wang Y J Transl Med; 2013 Aug; 11():186. PubMed ID: 23937717 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells. Bugide S; Green MR; Wajapeyee N Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3509-E3518. PubMed ID: 29581297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]